Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-7.37	-11.10	-10.34
Graham Fair Price	-36.00	6.89	10.76
PEG	251.17	0.03	< 0.005
Price/Book	-28.56	0.69	0.96
Price/Cash Flow	-16.17	-7.58	-6.52
Prices/Earnings	-56.82	-1.71	-1.09
Price/Sales	33.38	16.78	12.58
Price/FCF	-16.17	-7.58	-6.52
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-32.20	-1.32	-1.00
Operating Margin	23.44	-2.16	-2.82
ROA	53.43	-0.06	-0.13
ROE	-0.22	-0.10	54.44
ROIC	-0.16	-0.07	58.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-359.39
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.28	0.59	-54.42
EPS QOQ	-1.28	0.57	-55.34
FCF QOQ	-0.04	0.38	751.00
Revenue QOQ	0.12	-0.46	288.66
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	194.65	314.42	61.53
Days Sales Outstanding (DSO)	149.92	208.65	39.18
Inventory Turnover	0.46	0.29	-38.09
Debt/Capitalization	0.25	0.24	-2.24
Quick Ratio	0.52	0.50	-5.34
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.82	4.57	-5.18
Cash	0.22	0.27	20.11
Capex	-0.31	-0.15	50.22
Free Cash Flow	-0.71	-0.42	41.69
Revenue	0.37	0.19	-49.21
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.85	1.94	4.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.38	-3.09	-29.92
Naive Interpretation	Member

06 - Financial Health · Weak

Rating